Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases

References

• CreasmanWTOdicinoFMaisonneuvePCarcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological CancerInt J Gynaecol Obstet200695Suppl 1S105S143
   PubMedGoogle Scholar
• HendricksonMRossJEifelPMartinezAKempsonRUterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinomaAm J Surg Pathol198262931087102898
   PubMed Web of Science ®Google Scholar
• RosenbergPBoerydBSimonsenEA new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancerGynecol Oncol199348132378423019
   PubMed Web of Science ®Google Scholar
• BenitoVLubranoAArencibiaOPure papillary serous tumors of the endometrium: a clinicopathological analysis of 61 cases from a single institutionInt J Gynecol Cancer20091981364136920009891
   PubMed Web of Science ®Google Scholar
• SolmazUMatEEkinAOptimal cytoreduction, depth of myo-metrial invasion, and age are independent prognostic factors for survival in women with uterine papillary serous and clear cell carcinomasInt J Surg201632717727365052
   PubMed Web of Science ®Google Scholar
• del CarmenMGBirrerMSchorgeJOUterine papillary serous cancer: a review of the literatureGynecol Oncol2012127365166123000148
   PubMed Web of Science ®Google Scholar
• HuangCYTangYHChiangYCImpact of management on the prognosis of pure uterine papillary serous cancer – a Taiwanese Gynecologic Oncology Group (TGOG) studyGynecol Oncol2014133222122824556064
   PubMed Web of Science ®Google Scholar
• CreasmanWTKohlerMFOdicinoFMaisonneuvePBoylePPrognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometriumGynecol Oncol200495359359615581969
   PubMed Web of Science ®Google Scholar
• SlomovitzBMBurkeTWEifelPJUterine papillary serous carcinoma (UPSC): a single institution review of 129 casesGynecol Oncol200391346346914675663
   PubMed Web of Science ®Google Scholar
• PodratzKCMarianiAUterine papillary serous carcinomas: the exigency for clinical trialsGynecol Oncol200391346146214675662
   PubMed Web of Science ®Google Scholar
• HamiltonCAKappDSChanJKClinical aspects of uterine papillary serous carcinomaCurr Opin Obstet Gynecol2008201263318197002
   PubMed Web of Science ®Google Scholar
• StellooENoutRANavesLCHigh concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinomaGynecol Oncol2014133219720424556061
   PubMed Web of Science ®Google Scholar
• VisserNCMReijnenCMassugerL FAGNagtegaalIDBultenJPijnenborgJMAAccuracy of Endometrial Sampling in Endometrial Carcinoma: A Systematic Review and Meta-analysisObstet Gynecol2017130480381328885397
   PubMed Web of Science ®Google Scholar
• MartinelliFDittoABoganiGAccuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignanciesJ Cancer Res Clin Oncol201714371275127928247037
   PubMed Web of Science ®Google Scholar
• ChenJClarkLHKongWMDoes hysteroscopy worsen prognosis in women with type II endometrial carcinoma?PLoS One2017123e017422628334032
   PubMed Web of Science ®Google Scholar
• HavrileskyLJSecordAABae-JumpVOutcomes in surgical stage I uterine papillary serous carcinomaGynecol Oncol2007105367768217355889
   PubMed Web of Science ®Google Scholar
• ColomboNCreutzbergCAmantFESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-upAnn Oncol2016271164126634381
   PubMed Web of Science ®Google Scholar
• BendifallahSCanlorbeGCollinetPJust how accurate are the major risk stratification systems for early-stage endometrial cancer?Br J Cancer2015112579380125675149
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NetworkKandothCSchultzNIntegrated genomic characterization of endometrial carcinomaNature20134977447677323636398
   PubMed Web of Science ®Google Scholar
• HoangLNKinlochMALeoJMInterobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular SubgroupAm J Surg Pathol201741224525228079598
   PubMed Web of Science ®Google Scholar
• TalhoukAHoangLNMcConechyMKMolecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatmentGynecol Oncol20161431465327421752
   PubMed Web of Science ®Google Scholar
• BanderaCDizonDSContemporary approaches to High-risk, Early-Stage Serous Endometrial Cancer: Clinical Equipoise PersistsAm J Clin Oncol Epub2018630
   Web of Science ®Google Scholar
• MahdiHElshaikhMADeBenardoRImpact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution studyGynecol Oncol2015137223924425641568
   PubMed Web of Science ®Google Scholar
• FrimerMHouJYMcAndrewTCGoldbergGLShahabiSThe clinical relevance of rising CA-125 levels within the normal range in patients with uterine papillary serous cancerReprod Sci201320444945522995987
   PubMed Web of Science ®Google Scholar
• GuptaDGunterMJYangKPerformance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinomaInt J Gynecol Cancer201121352953421436701
   PubMed Web of Science ®Google Scholar
• LinJFMuñizKSukumvanichPSurvival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database studyBJOG2016123111846185226537059
   PubMed Web of Science ®Google Scholar
• BlackCFengABittingerSQuinnMNeeshamDMcNallyOUterine Papillary Serous Carcinoma: A Single-Institution Review of 62 CasesInt J Gynecol Cancer201626113314026588230
   PubMed Web of Science ®Google Scholar
• SolmazUEkinAMatEAnalysis of clinical and pathological characteristics, treatment methods, survival, and prognosis of uterine papillary serous carcinomaTumori2016102659359927514313
   PubMed Web of Science ®Google Scholar
• FaderANDrakeRDO’MalleyDMUterine Papillary Serous Carcinoma (UPSC) ConsortiumPlatinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinomaCancer2009115102119212719306417
   PubMed Web of Science ®Google Scholar
• Rauh-HainJAGrowdonWBSchorgeJOPrognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinomaGynecol Oncol2010119229930420691465
   PubMed Web of Science ®Google Scholar
• ThomasMBMarianiAClibyWAKeeneyGLPodratzKCDowdySCRole of cytoreduction in stage III and IV uterine papillary serous carcinomaGynecol Oncol2007107219019317825394
   PubMed Web of Science ®Google Scholar
• ViswanathanANMacklinEABerkowitzRMatulonisUThe importance of chemotherapy and radiation in uterine papillary serous carcinomaGynecol Oncol2011123354254721963091
   PubMed Web of Science ®Google Scholar
• WinerIAhmedQFMertISignificance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?Int J Gynecol Pathol2015341475625473753
   PubMed Web of Science ®Google Scholar
• GrowdonWBRauh-HainJJCordonAPrognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional reviewInt J Gynecol Cancer201222341742422237383
   PubMed Web of Science ®Google Scholar
• BristowREAsrariFTrimbleELMontzFJExtended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) diseaseGynecol Oncol200181227928611330963
   PubMed Web of Science ®Google Scholar
• MendivilASchulerKMGehrigPANon-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypesCancer Control2009161465219078929
   PubMed Web of Science ®Google Scholar
• FaderANNagelCAxtellAEUPSC ConsortiumStage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomesGynecol Oncol2009112355856219118888
   PubMed Web of Science ®Google Scholar
• GoldbergHMillerRCAbdah-BortnyakROutcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)Gynecol Oncol2008108229830518096209
   PubMed Web of Science ®Google Scholar
• SuttonGAxelrodJHBundyBNAdjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology GroupGynecol Oncol2006100234935416213007
   PubMed Web of Science ®Google Scholar
• van der PuttenLJHoskinsPTinkerALimPAquino-ParsonsCKwonJSPopulation-based treatment and outcomes of Stage I uterine serous carcinomaGynecol Oncol20141321616424219983
   PubMed Web of Science ®Google Scholar
• HuhWKPowellMLeathCA3rdUterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapyGynecol Oncol200391347047514675664
   PubMed Web of Science ®Google Scholar
• CraigheadPSSaitKStuartGCManagement of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994Gynecol Oncol200077224825310785473
   PubMed Web of Science ®Google Scholar
• GriceJEkMGreerBUterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patientsGynecol Oncol199869169739571001
   PubMed Web of Science ®Google Scholar
• BoyrazGSalmanMCBasaranDExtrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter StudyInt J Gynecol Cancer201727110210827668395
   PubMed Web of Science ®Google Scholar
• TchaboNEMcCloskeySMashtareTLTreatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992–2006Gynecol Oncol2009115224925619692115
   PubMed Web of Science ®Google Scholar
• ChamSHuangYTergasAIUtility of radiation therapy for early-stage uterine papillary serous carcinomaGynecol Oncol2017145226927628343693
   PubMed Web of Science ®Google Scholar
• HongJCFooteJBroadwaterGGaillardSHavrileskyLJChinoJPImpact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the UterusInt J Gynecol Cancer201727472072928375927
   PubMed Web of Science ®Google Scholar
• SecordAAHavrileskyLJO’MalleyDMA multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancerGynecol Oncol2009114344244719560193
   PubMed Web of Science ®Google Scholar
• Shechter-MaorGBruchimIBen-HarimZAltarasMFishmanACombined chemotherapy regimen of carboplatin and paclitaxel as adjuvant treatment for papillary serous and clear cell endometrial cancerInt J Gynecol Cancer200919466266419509567
   PubMed Web of Science ®Google Scholar
• ChenJRChangTCFuHCOutcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article)Medicine (Baltimore)20169515e333027082583
   PubMed Web of Science ®Google Scholar